Report : North America Arterial Blood Gas Kits Market Forecast to 2030 – Regional Analysis – by Product (Luer Lock Syringe and Luer Slip Syringe), Type (Non-Vented and Vented), Usage (Pre-set plunger mode and Manual Aspiration), Application (In vitro diagnostics, Electrolyte Analysis, and pH blood gas), Needle Gauge (23 G to 25 G and Less than 23 G), Syringe Volume (1 ml, 3 ml, and Others), and End User (Hospitals, Clinics, and Others)
At 7.4% CAGR, the North America Arterial Blood Gas Kits Market is Speculated to be Worth US$ 476.57 million by 2030, says The Business Market Insights
According to the Business Market Insights’ research, the North America arterial blood gas kits market was valued at US$ 269.51 million in 2022 and is expected to reach US$ 476.57 million by 2030, registering a CAGR of 7.4% from 2022 to 2030. Increasing prevalence of respiratory diseases and growing prevalence of metabolic and kidney diseases are the critical factors attributed to the North America arterial blood gas kits market expansion.
Chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other respiratory diseases are creating a huge burden on the public healthcare system in various countries across the world. Smoking, infections, and genetic factors can cause serious respiratory complications. In 2021, The American Lung Association reported that COPD is the third leading cause of death in the US, and over 16.4 million people are diagnosed with the condition. According to the Asthma and Allergy Foundation of America, ∼ 26 million people in the US had asthma in 2022, which is one of the most common respiratory diseases in the world. Patients suffering from respiratory disorders usually experience breathing issues and oxygen shortages. Arterial blood gas (ABG) test is carried out to measure the amount of oxygen and carbon dioxide dissolved in arterial blood. The test helps deliver care to patients suffering from acute and chronic respiratory disease. Thus, the growing prevalence of acute and chronic respiratory diseases propels the demand for arterial blood gas test kits.
On the contrary, risks, complications, and sampling errors associated with arterial blood sampling hurdles the growth of North America arterial blood gas kits market.
Based on product, the North America arterial blood gas kits market is segmented into luer lock syringe and luer slip syringe. The luer lock syringe segment held 74.8% share of North America arterial blood gas kits market in 2022, amassing US$ 201.63 million. It is projected to garner US$ 375.49 million by 2030 to expand at 8.1% CAGR during 2022–2030.
Based on type, the North America arterial blood gas kits market is segmented into vented and non-vented. The non-vented segment held 78.6% share of North America arterial blood gas kits market in 2022, amassing US$ 211.84 million. It is projected to garner US$ 384.45 million by 2030 to expand at 7.7% CAGR during 2022–2030.
Based on usage, the North America arterial blood gas kits market is segmented into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held 81.7% share of North America arterial blood gas kits market in 2022, amassing US$ 220.28 million. It is projected to garner US$ 404.86 million by 2030 to expand at 7.9% CAGR during 2022–2030.
Based on application, the North America arterial blood gas kits market is segmented into In vitro diagnostics, electrolyte analysis, and pH blood gas. The In vitro diagnostics segment held 42.8% share of North America arterial blood gas kits market in 2022, amassing US$ 115.29 million. It is projected to garner US$ 213.17 million by 2030 to expand at 8.0% CAGR during 2022–2030.
Based on needle guage, the North America arterial blood gas kits market is segmented into 23 G to 25 G and less than 23 G. The 23 G to 25 G segment held 72.5% share of North America arterial blood gas kits market in 2022, amassing US$ 195.44 million. It is projected to garner US$ 355.06 million by 2030 to expand at 7.7% CAGR during 2022–2030.
Based on syringe volume, the North America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3 ml segment held 45.4% share of North America arterial blood gas kits market in 2022, amassing US$ 122.38 million. It is projected to garner US$ 222.05 million by 2030 to expand at 7.7% CAGR during 2022–2030.
Based on end user, the North America arterial blood gas kits market is segmented into hospitals, clinics, and others. The hospitals segment held 51.5% share of North America arterial blood gas kits market in 2022, amassing US$ 138.82 million. It is projected to garner US$ 248.09 million by 2030 to expand at 7.5% CAGR during 2022–2030.
Based on country, the North America arterial blood gas kits market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.4% share of North America arterial blood gas kits market in 2022. It was assessed at US$ 224.88 million in 2022 and is likely to hit US$ 402.44 million by 2030, exhibiting a CAGR of 7.5% during 2022–2030.
Key players operating in the North America arterial blood gas kits market are Becton Dickinson and Co, Vyaire Medical Inc, Opti Medical Systems, ICU Medical Inc, SunMed LLC, Trudell Healthcare Solutions Inc, Siemens Healthineers AG, Radiometer Medical ApS, ITL health Group Ltd, Medline Industries LP, Cardinal Health Inc, Fisher Scientific International Inc, and Teleflex Inc, among others.
- In April 2022, Siemens Healthineers has received U.S. Food and Drug Administration approval for RAPIDPoint 500e Blood Gas Analyzer. RAPIDLyte Arterial Sampling Syringes and RAPIDLyte Multicap Capillaries offered by Siemens are compatible with RAPIDPoint 500e Blood Gas System. This product approval strengthens the market position of the company.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com